Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 7566842.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the outcome of cervical squamous intraepithelial lesions (SIL) in human immunodeficiency virus (HIV)-seropositive women. Papanicolaou smears were followed-up prospectively in a group of 60 HIV-positive women every 6 months for 18 months. The cumulative incidence of SIL at 18 months was 9% in 27 women who presented with normal Papanicolaou smears at entry. In 33 women who initially presented with SIL, the rate of persistence of cervical lesions was 95% (18 of 19) in untreated patients and 61% (eight of 13) in women who underwent surgery. In women with low-grade SIL, the persistence or progression of cervical lesions was observed in 92% of the cases (12 of 13). No invasive cancer was observed during the 18 months of the study period. Although the long-term outcome of SIL in this population remains unknown, our results emphasize the high rate of persistence of SIL and the relative inefficiency of conventional treatment in HIV-infected women. These findings contrast with the natural history of SIL in immunocompetent women.
Medical subject headings
- HIV Seropositivity
- HIV-1
- Papanicolaou Test
- Uterine Cervical Neoplasms
- Vaginal Smears
- Uterine Cervical Dysplasia